3
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Proteinuria After Human Renal Transplantation: I. Urinary Excretion of α2-Microglobulin (Retinol-binding Protein), β2-Microglobulin, Lysozyme and Albumin

Pages 37-44 | Accepted 07 Nov 1972, Published online: 09 Jul 2009
 

Abstract

With the use of the protein/creatinine clearance ratio (CP/Ccr), calculated from immunochemical determinations of α2-microglobulin (retinol-binding protein), &microglobulin, lysozyme and albumin, proteinuria was studied during the early course of human renal transplantation. When substantial changes of creatinine clearance (Ccr) occurred, an inverse relationship was found between Ccr and Cp/Ccr for all four proteins. An exception was seen during the first days of six acute rejection crises, where opposite changes were observed in Cr/Ccr for albumin and the low molecular weight proteins. A slight but significant increase of albumin excretion related to Ccr was found during and after rejection crises, but for none of the proteins did the changes in Cr/Ccr precede other signs of acute rejection crisis.

The value of different methods expressing proteinuria after renal transplantation is discussed. It is concluded that more precise information is gained by calculating Cp/Ccr for specific proteins, as this parameter more truly reflects the mean protein excretion per nephron.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.